Page last updated: 2024-10-18

dihydroxyphenylalanine and Moniliasis, Oral

dihydroxyphenylalanine has been researched along with Moniliasis, Oral in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research Excerpts

ExcerptRelevanceReference
"Uremic stomatitis has classically been divided into ulcerative and nonulcerative types."1.25Unusual oral lesions in a uremic patient. Review of the literature and report of a case. ( Jaspers, MT, 1975)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jaspers, MT1
Walsh, LJ1
Cleveland, DB1
Cumming, CG1

Other Studies

2 other studies available for dihydroxyphenylalanine and Moniliasis, Oral

ArticleYear
Unusual oral lesions in a uremic patient. Review of the literature and report of a case.
    Oral surgery, oral medicine, and oral pathology, 1975, Volume: 39, Issue:6

    Topics: Adult; Biopsy; Candidiasis, Oral; Coloring Agents; Diagnosis, Differential; Dihydroxyphenylalanine;

1975
Quantitative evaluation of Langerhans cells in median rhomboid glossitis.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1992, Volume: 21, Issue:1

    Topics: Candidiasis, Oral; Cell Count; Dihydroxyphenylalanine; Glossitis; HLA-DR Antigens; Humans; Immunoenz

1992